✦ LIBER ✦

Prevention of the volume expansion induced suppression of aldosterone by rosiglitazone, in type 2 diabetic subjects

✍ Scribed by Nirupam Goenka; Christina Kotonya; Michael D. Penney; Paul O’Hare

Book ID: 117602112
Publisher: Nature Publishing Group
Year: 2003
Tongue: English
Weight: 55 KB
Volume: 16
Category: Article
ISSN: 0895-7061
DOI: 10.1016/s0895-7061(03)00515-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prevention of nutritionally induced diab

Prevention of nutritionally induced diabetes by rosiglitazone in the gerbil Psammomys obesus

✍ Simona Hefetz; Ehud Ziv; Anne Jörns; Sigurd Lenzen; Eleazar Shafrir 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB

Rosiglitazone prevents diabetes by incre

Rosiglitazone prevents diabetes by increasing beta-cell mass in an animal model of type 2 diabetes characterized by reduced beta-cell mass at birth

✍ A. C. Holloway; J. J. Petrik; J. E. Bruin; H. C. Gerstein 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 243 KB

Prevention of Type 2 Diabetes Mellitus b

Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance

✍ Tuomilehto, Jaakko; Lindström, Jaana; Eriksson, Johan G.; Valle, Timo T.; Hämälä 📂 Article 📅 2001 🏛 Massachusetts Medical Society 🌐 English ⚖ 170 KB

Gastroprotective effects of the insulin

Gastroprotective effects of the insulin sensitizers rosiglitazone and metformin against indomethacin-induced gastric ulcers in Type 2 diabetic rats

✍ Mohamed A Morsy; Osama M Ashour; Amr A Fouad; Seham A Abdel-Gaber 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB

Prevention of Type 2 Diabetes || Decreas

Prevention of Type 2 Diabetes || Decreasing Postprandial Plasma Glucose Using an α-Glucosidase Inhibitor in Subjects with IGT for the Prevention of Type 2 Diabetes Mellitus: The STOP-NIDDM Trial

✍ LeRoith, Derek 📂 Article 📅 2012 🏛 Springer New York 🌐 English ⚖ 597 KB

There Is A World-wide Epidemic On Obesity. This Epidemic Is Driving The Immense Proportions Of Type 2 Diabetes Across The Globe. While There Are Numerous Therapies For Treating Type 2 Diabetes, The Most Effective Therapy Is Prevention. Prevention Of Type 2 Diabetes Can Be Achieved Properly By Simult

The Phosphodiesterase Inhibitor Cilostaz

The Phosphodiesterase Inhibitor Cilostazol Induces Regression of Carotid Atherosclerosis in Subjects With Type 2 Diabetes Mellitus Principal Results of the Diabetic Atherosclerosis Prevention by Cilostazol (DAPC) Study: A Randomized Trial

✍ N. Katakami; Y.-S. Kim; R. Kawamori 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 83 KB